Correspondence on “Differential Impact of Concomitant Methotrexate and Glucocorticoid Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study”

Key Points

• This correspondence addresses the need to understand how varying doses of methotrexate and glucocorticoids affect biologics and JAK inhibitors.
• No datasets were generated or analyzed during the study.
• Data sharing is not applicable.
• No specific results were presented as no datasets were generated.